![](https://www.ibj.com/wp-content/uploads/2022/11/Roche-Diagnostics-Pilot-At-Home-COVID-Test-300x169.jpg)
Roche launches brand for at-home COVID test
The test is the first over-the-counter test distributed in the U.S. by Roche Diagnostics, which has its North American headquarters in Indianapolis.
The test is the first over-the-counter test distributed in the U.S. by Roche Diagnostics, which has its North American headquarters in Indianapolis.
The high-tech approach allows a patient recovering from substance abuse to interact with potential future versions of himself or herself.
A former IndyGo bus could start a second life by the end of the year—distributing fresh food, providing nutrition education and troubleshooting problems Indianapolis residents have applying for food stamps.
A trend called “active adult communities” translates to age-specific housing that has eliminated dining, transportation and cleaning services.
After 15 years of coaxing and cajoling the medical community to consider a different way to do brain surgery, NICO co-founder Jim Pearson has numbers to show more surgeons and investors are buying into his vision.
The IU School of Medicine announced won a five-year, $48.8 million grant from the National Institute on Aging, a division of the National Institutes of Health, to create in mice genetic mutations similar to those found in people with late-onset Alzheimer’s.
The FDA cleared the COVID-19 booster tweaks without requiring human test results—just like it approves yearly changes to flu vaccines.
Between 7 million and 23 million Americans—including 1 million who can no longer work—are suffering from the long-term effects of infection with the virus, according to government estimates.
Host Mason King talks with Dr. Cameual Wright and Jack E. Turman Jr. about the Housing Equity for Infant Health Initiative, a program that will provide support for pregnant women and mothers with infants under 1 year old.
Indianapolis and Denver have been selected as two cities that will work with the Maryland-based Partnership for a Healthier America and the International Fresh Produce Association, a Delaware-based trade group, to try to double residents’ consumption of fruit and vegetables.
The national study co-authored by researchers at Indianapolis-based Regenstrief Institute and other agencies across the country was designed to gauge the effectiveness and durability of the third and fourth doses of COVID vaccine boosters.
Point Biopharma is moving aggressively to get its lead drug, a radioactive isotope called lutetium 177, through late-stage trials for prostate cancer.
The FDA approved the drug from Amylyx Pharmaceuticals based on results from one small, mid-stage study in which patients with the debilitating disease appeared to progress more slowly and survive several months longer.
Three Indiana institutions are teaming up to try to develop a treatment for glioblastoma, a lethal cancer that begins with the brain or spinal cord, and is difficult to treat, often requiring a combination of surgery, chemotherapy and radiation.
The new estimate is a dramatic increase from the roughly $16 billion in potential fraud identified a year ago, and it illustrates the immense task still ahead of Washington as it seeks to pinpoint the losses, recover the funds and hold criminals accountable.
InnovAge Holding Corp. had planned to offer services in Terre Haute starting in 2024, with a goal to enroll more than 600 seniors.
Doctors and public health experts never expected there would be so little interest in vaccines for young children.
The federal No Surprises Act—which took effect Jan. 1 and protects patients from receiving surprise medical bills resulting from unexpected, out-of-network coverage—is already creating huge waves.
In recent months, current and former employees of drugmaker Eli Lilly and Co., medical-equipment maker Roche Diagnostics and health care system Ascension St. Vincent have filed suit in federal district court, claiming their religious views and civil liberties were violated.
The federal government has purchased more than 170 million doses of the updated boosters, and doses began shipping last week, following authorization by the Food and Drug Administration.